Literature DB >> 8970529

Energy-based scatter corrections for scintillation camera images of iodine-131.

K R Pollard1, T K Lewellen, M S Kaplan, D R Haynor, R S Miyaoka, J F Eary, L D Durack.   

Abstract

UNLABELLED: The use of high-dose 131I antibody therapy requires accurate measurement of normal tissue uptake to optimize the therapeutic dose. One of the factors limiting the accuracy of such measurements is scatter and collimator septal penetration. This study evaluated two classes of energy-based scatter corrections for quantitative 131I imaging: window-based and spectrum-fitting.
METHODS: The window-based approaches estimate scatter from data in two or three energy windows placed on either side of the 364-keV photopeak using empirical weighting factors. A set of images from spheres in an elliptical phantom were used to evaluate each of the window-based corrections. The spectrum-fitting technique estimates detected scatter at each pixel by fitting the observed energy spectrum with a function that models the photopeak and scatter, and which incorporates the response function of the camera. This technique was evaluated using a set of Rollo phantom images.
RESULTS: All of the window-based methods performed significantly better than a single photopeak window (338-389 keV), but the weighting factors were found to depend on the object being imaged. For images contaminated with scatter, the spectrum-fitting method significantly improved quantitation over photopeak windowing. Little difference, however, between any of the methods was observed for images containing small amounts of scatter.
CONCLUSION: Most clinical 131I imaging protocols will benefit from qualitative and quantitative improvements provided by the spectrum-fitting scatter correction. The technique offers the practical advantage that it does not require phantom-based calibrations. Finally, our results suggest that septal penetration and scatter in the collimator and other detector-head components are important sources of error in quantitative 131I images.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970529

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging.

Authors:  Y K Dewaraja; M Ljungberg; K F Koral
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

2.  Tc-99m sestamibi myocardial perfusion imaging after undisclosed I-131 therapy.

Authors:  Andrew F Robertson; Paul J Roach; Melissa A Shields; Dale L Bailey
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

3.  Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study.

Authors:  Y K Dewaraja; M Ljungberg; K F Koral
Journal:  J Nucl Med       Date:  2000-10       Impact factor: 10.057

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.